Thomas Pabst

Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-α (C/EBPα), in acute myeloid leukemia

Thomas Pabst, Beatrice U. Mueller, Pu Zhang et al. · Nature Genetics · 2001 · 903 citations

Hematological Malignancy, Tumor Biology, Transcriptional Regulation +10

AML1–ETO downregulates the granulocytic differentiation factor C/EBPα in t(8;21) myeloid leukemia

Thomas Pabst, Beatrice U. Mueller, Nari Harakawa et al. · Nature Medicine · 2001 · 462 citations

Hematological Malignancy, Hematology, Immunology +8

Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death

Abhishek D. Garg, Lorenzo Galluzzi, Lionel Apétoh et al. · Frontiers in Immunology · 2015 · 381 citations · Full text

Apoptosis, Immunology, Cell Death +23

Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells

Nimitha R. Mathew, Francis Baumgartner, Lukas M. Braun et al. · Nature Medicine · 2018 · 283 citations · Full text

Cell Therapy, Flt3-itd-mutant Leukemia Cells, Immunology +7

Aberrant Lipid Metabolism in Hepatocellular Carcinoma Revealed by Plasma Metabolomics and Lipid Profiling

Andrew D. Patterson, Olivier Maurhofer, Diren Beyoğlu et al. · Cancer Research · 2011 · 261 citations · Full text

Metabolomic Profiling, Pathology, Hcc Plasma +21